Novo Nordisk partners with OpenAI as AI drug discovery hopes mount
[ad_1] People walk past a sign for Novo Nordisk’s annual general meeting at the entrance to the venue in Copenhagen, Denmark, March 26, 2026. Tom Little | Reuters Novo Nordisk is partnering with OpenAI to “bring new and better treatment options to patients faster,” the Danish drugmaker said Tuesday. The partnership will enable Novo to […]
Trump policies, China’s biotech boom are ending Europe’s pharma powerhouse era
[ad_1] Boxes of medication are seen on the shelves of the Keencare pharmacy, a member of the Green Light Group, on September 19, 2024 in London, England. Leon Neal | Getty Images News | Getty Images Once the go-to location for global drugmakers, Europe is now being squeezed by President Donald Trump’s aggressive trade and […]
FDA approves new daily GLP-1 pill — what to know, including how they compare to Wegovy tablets
[ad_1] *Gulp* Much to the relief of the needle-shy, the FDA has just approved a second oral GLP-1 drug, following the release of the semaglutide Wegovy pill in January. But this new tablet, from pharma giant Eli Lilly, promises to be even more convenient than its predecessor with similar, if slightly less drastic, weight-trimming results. […]
Novo Nordisk says Wegovy pill outperforms Lilly’s oral GLP-1 in cross-trial comparison
[ad_1] Wegovy semaglutide tablets. Michael Siluk | Universal Images Group | Getty Images The Wegovy pill showed more pronounced weight loss and less cumbersome side effects than Eli Lilly‘s rival pill that was approved this week, Novo Nordisk said Thursday. Oral Wegovy demonstrated “significantly greater mean weight loss” than orforglipron, which Lilly will sell under […]
Novo Nordisk shares rise after Wegovy recommended by Britain’s drug price regulator
[ad_1] Michael Siluk | UCG | Universal Images Group | Getty Images Novo Nordisk rose as much as 4% after England’s drug price regulator recommended the use of its best-selling drug Wegovy to prevent heart attacks and strokes. Wegovy is mainly a weight loss treatment but it is also approved for reducing the risk of […]
AstraZeneca stock jumps after surprise trial win for lung disease drug where rivals have failed
[ad_1] AstraZeneca‘s stock jumped nearly 5% after Britain’s most valuable company said its experimental lung disease medicine met its target in two late-stage clinical trials. The respiratory treatment tozorakimab, reduced flare-ups of chronic obstructive pulmonary disease (COPD) in both former smokers and in the overall population versus placebo, the company said. “This marks a notable […]
Novartis shells out $2 billion for immunology biotech Excellergy, in second multi-billion dollar deal in a week
[ad_1] A sign of Swiss pharmaceutical giant Novartis is seen on the top of a building at Novartis Campus in Basel, northern Switzerland, on Sept. 9, 2025. Fabrice Coffrini | AFP | Getty Images Novartis is planning to buy U.S.-based biotech Excellergy for up to $2 billion, betting on a next-generation allergy treatment that may […]
Abivax in no rush for a deal, confident key June trial data can secure better terms for partnerships, CEO tells CNBC
[ad_1] Abivax is planning to raise money after releasing key trial data in June, its CEO told CNBC on Tuesday, signaling to potential buyers of the firm that it is in no rush to sell. Intense takeover rumors have surrounded the French biotech company for months, impacting the volatile stock that rose nearly 1,700% in […]
FDA approves higher dose version of weight loss drug Wegovy as Novo Nordisk tries to win back market share
[ad_1] The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark, Feb. 4, 2026. Tom Little | Reuters The Food and Drug Administration on Thursday approved a higher-dose version of Novo Nordisk‘s blockbuster weight loss injection Wegovy, as the company pushes to win back market share from […]
Eli Lilly’s next-generation obesity drug retatrutide clears first late-stage diabetes trial
[ad_1] Eli Lilly on Thursday said its next-generation obesity drug retatrutide cleared its first late-stage trial on Type 2 diabetes patients, helping them manage their blood sugar levels and lose weight. The drug lowered hemoglobin A1c — a key measure of blood sugar levels — by an average of 1.7% to 2% across different doses […]